Interferon γ: a crucial role in the function of induced regulatory T cells in vivo

Trends in Immunology

Volumn 27, Issue 4, 2006, Pages 183-187

  Wood, Kathryn J ^a   Sawitzki, Birgit ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CD28 ANTIGEN; CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; GAMMA INTERFERON RECEPTOR 2; HEME OXYGENASE 1; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; MONOCLONAL ANTIBODY CD28; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; MICROENVIRONMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; UVEITIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 33645878295     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2006.02.008     Document Type: Article

References (53)

1. Tarrant T., et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide and apoptosis. J. Exp. Med. 189 (1999) 219-230
2. Dalton D., et al. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192 (2000) 117-122
3. + T cells for IL-4 production. J. Exp. Med. 199 (2004) 1619-1630
4. + regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201 (2005) 1925-1935
5. + regulatory T cell function in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFNγ. Arthritis Res. Ther. 7 (2005) R402-R415
6. Konieczny B., et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160 (1998) 2059-2064
7. Hassan A., et al. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-γ: implications for long-term allograft acceptance. Transplantation 68 (1999) 124-129
8. Yu X., et al. CD28 ligation induces transplantation tolerance by IFN-g-dependent depletion of T cells that recognize alloantigens. J. Clin. Invest. 113 (2004) 1624-1630
9. Jones L., et al. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158 (1997) 5997-6005
10. Billiau A., et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140 (1988) 1506-1510
11. + myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-γ in autoimmune models. Trends Immunol. 22 (2001) 367-371
12. Kitching A., et al. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFNγ. J. Am. Soc. Nephrol. 15 (2004) 1764-1767
13. Flaishon L., et al. Cutting edge: anti-inflammatory properties of low levels of IFN-γ. J. Immunol. 168 (2002) 3707-3711
14. Gran B., et al. Early administration of IL-12 suppresses EAE through induction of interferon-γ. J. Neuroimmunol. 156 (2004) 123-131
15. Ponomarev E., et al. γδ T cell regulation of IFN-γ production by central nervous system infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 1587-1595
16. + regulatory T cells: implications of their broad repertoire and high self-reactivity for the maintenance of immunologic self-tolerance. Novartis Found. Symp. 252 (2003) 6-16
17. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3 (2003) 199-210
18. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16 (2004) 81-88
19. + regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen specific reactivation in vivo is critical for bystander regulation. Blood 105 (2005) 4871-4877
20. Hara M., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166 (2001) 3789-3796
21. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168 (2002) 1080-1086
22. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193 (2001) 1295-1301
23. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193 (2001) 1285-1294
24. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
25. + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease. J. Exp. Med. 199 (2004) 25-34
26. Shtrichman R., and Samuel C. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4 (2001) 251-259
27. Kishimoto K., et al. Th1 cytokines, programmed cell death and alloreactive T cell clone size in transplant tolerance. J. Clin. Invest. 109 (2002) 1471-1479
28. Refaeli Y., et al. Interferon γ is required for activation induced death of T lymphocytes. J. Exp. Med. 196 (2002) 999-1005
29. Tau G., et al. Interferon γ signalling alters the function of T helper type 1 cells. J. Exp. Med. 192 (2000) 977-986
30. Bernabei P., et al. Interferon γ receptor 2 expression as the deciding factor in human T, B and myeloid cell proliferation or death. J. Leukoc. Biol. 70 (2001) 950-960
31. + T cell function but not expansion. Nat. Immunol. 3 (2002) 1208-1213
32. + cells in vivo. J. Immunol. 172 (2004) 3391-3398
33. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. 172 (2004) 6539-6544
34. Tang Q., et al. Visualising regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006) 83-92
35. + T cell proliferation via an IFN-γ and nitric oxide dependent mechanism. J. Immunol. 167 (2001) 4293-4302
36. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
37. Fallarino F., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 (2003) 1206-1212
38. Moffett J., and Namboodiri M. Tryptophan and the immune response. Immunol. Cell Biol. 81 (2003) 247-265
39. Mellor A., and Munn D. Tryptophan catabolism and T cell tolerance: immunosuppression by starvation?. Immunol. Today 20 (1999) 469-473
40. Mellor A., and Munn D. IDO expression by dendritic cells: tolerance and tryptophan metabolism. Nat. Immunol. Rev. 4 (2004) 762-774
41. Sakurai K., et al. Effect of indoleamine 2,3-dioxygenase on induction of experimental allergic encephalomyelitis. J. Neuroimmunol. 129 (2002) 186-196
42. Fallarino F., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9 (2002) 1069-1077
43. Grohmann U., et al. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24 (2003) 242-248
44. Oh G., et al. 3-Hydroxyanthranilic acid, one of the metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 320 (2004) 1156-1162
45. + T cells. Biochem. Biophys. Res. Commun. 306 (2003) 701-705
46. Choi B., et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327 (2005) 1066-1071
47. + regulatory T cells. J. Immunol. 174 (2005) 5181-5186
48. Pae H., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation by inhibition of IL-2 production. J. Immunol. 172 (2004) 4744-4751
49. Malek T., and Bayer A. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4 (2004) 665-674
50. Dai Z., et al. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J. Immunol. 161 (1998) 1659-1663
51. Fontenot J., et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1150
52. + regulatory T cells in the absence of interleukin 2 signalling. Nat. Immunol. 6 (2005) 1152-1159
53. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralisation. J. Exp. Med. 201 (2005) 723-735